Cerity Partners
CLB icon

Cerity Partners’s Core Laboratories CLB Stock Holding History

Cerity Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,127
Closed -$117K – 2771
2025
Q2 		$117K Sell
10,127
-3,102
-23% -$36.8K ﹤0.01% 2457
2025
Q1 		$198K Sell
13,229
-3,243
-20% -$54.3K ﹤0.01% 2221
2024
Q4 		$293K Buy
16,472
+5,283
+47% +$102K ﹤0.01% 2045
2024
Q3 		$207K Buy
+11,189
New +$225K ﹤0.01% 2304
2024
Q2 		– Sell
-11,770
Closed -$201K – 2261
2024
Q1 		$201K Buy
+11,770
New +$185K ﹤0.01% 2108
2022
Q1 		– Sell
-10,218
Closed -$228K – 970
2021
Q4 		$228K Buy
+10,218
New +$266K ﹤0.01% 890

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Cerity Partners's CLB Position: Q3 2025 in Review

Cerity Partners sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 10,127 shares — an estimated $117K sold.

Cerity Partners first reported a position in CLB in Q4 2021 and held it in 6 quarters. The position peaked at $293K in Q4 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Cerity Partners reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Cerity Partners sold 10,127 Core Laboratories shares in Q3 2025, an estimated $117K.
  • Cerity Partners first reported a position in Core Laboratories in Q4 2021 and held it in 6 quarters.
  • Cerity Partners's Core Laboratories position peaked at $293K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.